| Business Name: |
Il Pharma Inc |
| Contact Person: |
Yuji Kuwabara |
| Address: |
1 Broadway Floor 14, Cambridge, Massachusetts 02142 |
| Phone Number: |
(617) 355-6910 |
| Annual Revenue (USD): |
Unknown |
| Founding Year: |
2007 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B & B2C |
| Business Category: |
|
| SIC Code: |
2834 |
| NAICS Code: |
325412 |
| Share This Business: |
|
| Related Businesses: |
Lipomed Inc - Cambridge, MA 02142
Newco Ls13 - Cambridge, MA 02142
Sanofi Us Services Inc - Cambridge, MA 02142
Shape Pharmaceuticals Inc - Cambridge, MA 02142
Verastem Inc - Cambridge, MA 02142
Targanta Therapeutics Corporation - Cambridge, MA 02142
Edimer Pharmaceuticals - Cambridge, MA 02142
Eleven Biotherapeutics - Cambridge, MA 02142
Constellation Pharmaceuticals - Cambridge, MA 02142
Millennium Pharmaceuticals - Cambridge, MA 02142
Aegerion Pharmaceuticals Inc - Cambridge, MA 02142
Via Cord LLC - Cambridge, MA 02142
Ironwood Pharmaceuticals Inc - Cambridge, MA 02142
Momenta Pharmaceuticals Inc - Cambridge, MA 02142
Alnylam Pharmaceuticals Inc - Cambridge, MA 02142
Sarepta Therapeutics Inc - Cambridge, MA 02142
Zalicus Inc - Cambridge, MA 02142
Clarus Ventures LLC - Cambridge, MA 02142
Gloucester Pharmaceuticals Inc - Cambridge, MA 02142
Akanas Therapeutics Inc - Cambridge, MA 02142
|
The company Il Pharma Inc provides BOTH services in the form of from its single location in Massachusetts.
1 to 4 employees work for Il Pharma Inc, and the business now earns Unknown per annum.
Il Pharma Inc was launched in 2007 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 .
To contact Il Pharma Inc, please call Yuji Kuwabara with the phone number (617) 355-6910 or visit its single location at 1 Broadway Floor 14 in Cambridge, Massachusetts 02142.
The location of the single location can also be found using the coordinates 42.362362,-71.083313.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.